Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe
De Luca, Andrea, Dunn, David, Zazzi, Maurizio, Camacho, Ricardo, Torti, Carlo, Fanti, Iuri, Kaiser, Rolf, Sönnerborg, Anders, Codoñer, Francisco M., Van Laethem, Kristel, Vandamme, Anne-Mieke, Bansi, Loveleen, Ghisetti, Valeria, van de Vijver, David A. M. C., Asboe, David, Prosperi, Mattia C. F., Di Giambenedetto, Simona
Published in The Journal of infectious diseases (15.04.2013)
Published in The Journal of infectious diseases (15.04.2013)
Get full text
Journal Article
Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance
Deforche, K., Silander, T., Camacho, R., Grossman, Z ., Soares, M. A., Van Laethem, K., Kantor, R., Moreau, Y., Vandamme, A.-M.
Published in Bioinformatics (15.12.2006)
Published in Bioinformatics (15.12.2006)
Get full text
Journal Article
Prediction of response to antiretroviral therapy by human experts and by the EuResist data‐driven expert system (the EVE study)
Zazzi, M, Kaiser, R, Sönnerborg, A, Struck, D, Altmann, A, Prosperi, M, Rosen‐Zvi, M, Petroczi, A, Peres, Y, Schülter, E, Boucher, CA, Brun‐Vezinet, F, Harrigan, PR, Morris, L, Obermeier, M, Perno, C‐F, Phanuphak, P, Pillay, D, Shafer, RW, Vandamme, A‐M, van Laethem, K, Wensing, AMJ, Lengauer, T, Incardona, F
Published in HIV medicine (01.04.2011)
Published in HIV medicine (01.04.2011)
Get full text
Journal Article
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations
Van Laethem, K, Van Vaerenbergh, K, Schmit, J C, Sprecher, S, Hermans, P, De Vroey, V, Schuurman, R, Harrer, T, Witvrouw, M, Van Wijngaerden, E, Stuyver, L, Van Ranst, M, Desmyter, J, De Clercq, E, Vandamme, A M
Published in Journal of acquired immune deficiency syndromes (1999) (01.10.1999)
Published in Journal of acquired immune deficiency syndromes (1999) (01.10.1999)
Get more information
Journal Article
Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment
Deforche, K., Camacho, R., Van Laethem, K., Lemey, P., Rambaut, A., Moreau, Y., Vandamme, A.-M.
Published in Bioinformatics (01.01.2008)
Published in Bioinformatics (01.01.2008)
Get full text
Journal Article
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort
Bartha, István, Assel, Matthias, Sloot, Peter M A, Zazzi, Maurizio, Torti, Carlo, Schülter, Eugen, De Luca, Andrea, Sönnerborg, Anders, Abecasis, Ana B, Van Laethem, Kristel, Rosi, Andrea, Svärd, Jenny, Paredes, Roger, van de Vijver, David A M C, Vandamme, Anne-Mieke, Müller, Viktor
Published in BMC infectious diseases (12.11.2013)
Published in BMC infectious diseases (12.11.2013)
Get full text
Journal Article
Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase
Megens, S., De Wit, S., Bernatchez, J., Dekeersmaeker, N., Vinken, L., Covens, K., Theys, K., Camacho, R. J., Vandamme, A.-M., Götte, M., Van Laethem, K.
Published in Acta clinica belgica (English ed. Online) (01.10.2014)
Published in Acta clinica belgica (English ed. Online) (01.10.2014)
Get full text
Journal Article
A18 Random amplification with next-generation sequencing to cover HIV and HCV full-length genomes
Cuypers, L., Conceição-Neto, N., Dierickx, T., Schrooten, Y., Vrancken, B., Van Wijngaerden, E., Nevens, F., Vandamme, A.-M., Matthijnssens, J., Van Laethem, K.
Published in Virus evolution (01.03.2017)
Published in Virus evolution (01.03.2017)
Get full text
Journal Article
Antiviral drug resistance in Cuban children infected with HIV‐1
Pérez, L, Alemán, Y, Correa, C, Aragonés, C, González, I, Pérez, J, Alvarez, A, Pérez, L, Kourí, V, Vandamme, A, Van Laethem, K
Published in Journal of the International AIDS Society (01.11.2012)
Published in Journal of the International AIDS Society (01.11.2012)
Get full text
Journal Article
Antiretroviral drug resistance in HIV‐1 therapy‐naïve patients in Cuba, 2006–2011
Pérez, L, Alemán, Y, Correa, C, Fonseca, C, Aragones, C, Alvarez, A, Kourí, V, Vandamme, A, Van Laethem, K
Published in Journal of the International AIDS Society (01.11.2012)
Published in Journal of the International AIDS Society (01.11.2012)
Get full text
Journal Article
Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood
VANDAMME, A.-M, VAN LAETHEM, K, SCHMIT, J.-C, VAN WIJNGAERDEN, E, REYNDERS, M, DEBYSER, Z, WITVROUW, M, VAN RANST, M, DE CLERCQ, E, DESMYTER, J
Published in European journal of clinical investigation (01.05.1999)
Published in European journal of clinical investigation (01.05.1999)
Get full text
Journal Article
Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy
Van Vaerenbergh, K, Van Laethem, K, Van Wijngaerden, E, Schmit, J C, Schneider, F, Ruiz, L, Clotet, B, Verhofstede, C, Van Wanzeele, F, Muyldermans, G, Simons, P, Stuyver, L, Hermans, P, Evans, C, De Clercq, E, Desmyter, J, Vandamme, A M
Published in AIDS research and human retroviruses (10.04.2000)
Published in AIDS research and human retroviruses (10.04.2000)
Get more information
Journal Article
A21 HIV-1 sub-subtype F1 outbreak among MSM in Belgium
Vinken, L., Fransen, K., Pineda-Peña, A.C., Alexiev, I., Balotta, C., Debaisieux, L., Devaux, C., García Ribas, S., Gomes, P., Incardona, F., Kaiser, R, Ruelle, J., Sayan, M., Paraschiv, S., Paredes, R., Peeters, M., Sonnerborg, A., Vancutsem, E., Van den Wijngaert, S., Van Ranst, M., Verhofstede, C., Vandamme, A.-M., Lemey, P., Van Laethem, K.
Published in Virus evolution (01.03.2017)
Published in Virus evolution (01.03.2017)
Get full text
Journal Article
Pradimicin-S is a Highly Soluble Non-peptidic Small-size Carbohydrate-binding Antibiotic that may Qualify as a Potential Drug Lead for HIV Treatment
Balzarini, J., François, K., Van Laethem, K., Hoorelbeke, B., Auwerx, J., Liekens, S., Igarashi, Y., Oki, T., Schols, D.
Published in Antiviral research (01.05.2009)
Published in Antiviral research (01.05.2009)
Get full text
Journal Article
Molecular epidemiology of antiretroviral resistance in therapy‐experienced HIV‐1 patients in Cuba (2009)
Pérez, L, Aleman, J, Correa, C, Pérez, J, Fonseca, C, Aragones, C, Pérez, D, Alvarez, A, Vandamme, AM, Kourí, V, Van Laethem, K
Published in Journal of the International AIDS Society (01.11.2010)
Published in Journal of the International AIDS Society (01.11.2010)
Get full text
Journal Article
Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes
Snoeck, J., Riva, C., Steegen, K., Schrooten, Y., Maes, B., Vergne, L., Van Laethem, K., Peeters, M., Vandamme, A.-M.
Published in Journal of virological methods (01.09.2005)
Published in Journal of virological methods (01.09.2005)
Get full text
Journal Article
Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors
Deforche, K., Camacho, R., Grossman, Z., Silander, T., Soares, M.A., Moreau, Y., Shafer, R.W., Van Laethem, K., Carvalho, A.P., Wynhoven, B., Cane, P., Snoeck, J., Clarke, J., Sirivichayakul, S., Ariyoshi, K., Holguin, A., Rudich, H., Rodrigues, R., Bouzas, M.B., Cahn, P., Brigido, L.F., Soriano, V., Sugiura, W., Phanuphak, P., Morris, L., Weber, J., Pillay, D., Tanuri, A., Harrigan, P.R., Shapiro, J.M., Katzenstein, D.A., Kantor, R., Vandamme, A.-M.
Published in Infection, genetics and evolution (01.06.2007)
Published in Infection, genetics and evolution (01.06.2007)
Get full text
Journal Article
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries
SCHMIT, J.-C, VAN LAETHEM, K, LISSEN, E, WITVROUW, M, DESMYTER, J, DE CLERCQ, E, VANDAMME, A.-M, RUIZ, L, HERMANS, P, SPRECHER, S, SÖNNERBORG, A, LEAL, M, HARRER, T, CLOTET, B, ARENDT, V
Published in AIDS (London) (22.10.1998)
Published in AIDS (London) (22.10.1998)
Get full text
Journal Article
Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients
Van Vaerenbergh, K, Harrer, T, Schmit, J-C, Carbonez, A, Fontaine, E, Kurowski, M, Grünke, M, Löw, P, Rascu, A, Schmidt, B, Schmitt, M, Thoelen, I, Walter, H, Van Laethem, K, Van Ranst, M, Desmyter, J, De Clercq, E, Vandamme, A-M
Published in AIDS research and human retroviruses (10.04.2002)
Published in AIDS research and human retroviruses (10.04.2002)
Get more information
Journal Article